A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
暂无分享，去创建一个
R. Leduc | M. Paetzel | N. Strynadka | F. Ban | A. Cherkasov | M. Niikura | L. Worrall | J. Pérez‐Vargas | S. Ennis | P. Levett | M. Krajden | F. Jean | S. Kovacic | Tirosh Shapira | C. Kenward | A. Ton | C. A. Thompson | R. N. Young | Pierre-Luc Boudreault | A. Olmstead | Joshua De Guzman | Ivan Villanueva | M. Vuckovic | Jaeyong Lee | Jason R. Smith | Svenja Dudek | Shutong Gang | Michael Bielecki | C. Hong | Danielle G Gordon